Health Care Sector Update for 04/23/2019: LENS, MBRX, WAT, JNJ, PFE, ABT, MRK, AMGN
Top Health Care Stocks:
Health care majors were trading higher pre-market Tuesday.
Early movers include:
(-) Presbia (LENS), which was sinking by more than 45% after saying the FDA likely won't grant pre-market approval (PMA) for the company's microlens product based on its current FDA staged pivotal clinical trial, but is likely to require a new, additional (albeit potentially abbreviated) clinical trial to be undertaken and completed prior to issuing any approval of PMA.
(-) Moleculin Biotech (MBRX) was plunging more than 50% after the biotechnology company said it will discuss a "significant discovery" for lung cancer at a conference call on Wednesday at 4:30 pm Eastern Time, as well as a fast track designation by the US Food and Drug Administration and recent corporate events.
(-) Waters (WAT) was declining more than 15% as it reported Q1 adjusted earnings of $1.60 per share compared to $1.59 per share in the first quarter of 2018. Analysts polled by Capital IQ had called for adjusted EPS of $1.73.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.